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stenosis could not discriminate it. However, it was unclear whether the difference of
lesion location affected the physiological severity. Therefore, we assessed the impact
of lesion location on fractional flow reserve (FFR) in intermediate coronary lesions.
Methods: We conducted FFR measurements in 170 consecutive patients with 195
intermediate coronary lesions which defined as 40-70% of diameter stenosis on
quantitative coronary angiography. All intermediate lesions were divided into three
groups such as the proximal, the mid, and the distal according to the location of
coronary artery. We compared the value of quantitative coronary angiography and the
FFR value among three locations.
Results: All 195 intermediate lesions were located at the proximal (n=63), the mid
(n=88), the distal (n=44) site of coronary artery. In all lesions, mean diameter stenosis
was 56.1%, mean lesion length was 18.7mm, and mean FFR value was 0.78. There
were no significant differences among three locations in diameter stenosis (56.6±7.8%
vs. 56.2±8.5% vs. 55.3±8.4%, p=0.72) and lesion length (19.3±11.8mm vs.
19.6±9.4mm vs. 15.8±8.2mm, p=0.10). We found significant differences in the FFR
value among them (0.75±0.12, 0.79±0.10, 0.83±0.12, p<0.01). There were significantly
lower FFR values in the proximal and the mid locations than in the distal location
(p<0.01, p<0.05, respectively). Physiological significance defined as the FFR value
<0.75 were observed 49.2% in the proximal, 35.2% in the mid, and 25.0% in the distal.
There was a significant difference among them (p=0.03).
Conclusion: This study suggests that the degree of myocardial perfusion territory can
affect physiological severity assessed with the FFR value in intermediate coronary
lesions.
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Background: Percutaneous coronary intervention (PCI) guided by fractional flow
reserve (FFR) measurement is superior to visual angiographic assessment. We have
developed a workflow that uses computational fluid dynamics (CFD) to compute the
FFR without use of invasive pressure measurement by virtual reconstruction of the
vessels from a single rotational coronary angiogram (RoCA).
Methods: 17 patients scheduled for elective PCI underwent RoCA and measurement
of FFR with a Combowire (Volcano), under rest and hyperaemic conditions.
Physiologically significant lesions were stented and the measurements repeated. 3D
reconstruction of the arterial tree was performed on a Philips 3DCA workstation. Flow
and pressure boundary conditions were extracted from the Combowire data and the
FFR and CFR also derived from the RoCA by CFD.
Results: We reconstructed the anatomy, and computed FFR and CFR, on all 19 vessels
and compared predictions with measured data from 11 lesions after stenting (the
remainder being not physiologically significant). The workflow was processed
successfully in all cases in c90 min, with a solution time of c24h.
Screenshot from the workflow showing coronary artery modelling.
Conclusion: We have developed a novel, effective and efficient workflow, including
a user-friendly graphical interface, to visualise 3DCA and compute FFR and CFR from
RoCA. Virtual interventions can be performed, and their physiological impact
predicted. A single RoCA can be used to provide accurate anatomical and physiological
information to guide therapy. Future work will be to refine and validate the system.
TCT-709
Contemporary Patterns of FFR and IVUS Use Among Patients Undergoing PCI
in the United States: Insights from the NCDR®
Philip B Dattilo1, Anand Prasad3, Emily Honeycutt2, Tracy Y Wang2, John C
Messenger1
1Cardiology, University of Colorado School of Medicine, Aurora, CO; 2Duke
Clinical Research Institute, Durham, NC; 3University of California at San Diego,
San Diego, CA
Background: Previous studies have demonstrated the utility of Fractional Flow
Reserve (FFR) and Intravascular Ultrasound (IVUS) in guiding percutaneous coronary
intervention (PCI) of coronary artery stenoses of intermediate severity. Contemporary
patterns of use of these technologies in the United States are unknown. We sought to
evaluate the current patterns of use of IVUS and FFR, as well as associated outcomes
in patients undergoing PCI for intermediate coronary lesions.
Methods: Patients with intermediate stenoses (40-70% by angiography) undergoing
PCI were analyzed using the National Cardiovascular Data Registry (NCDR) CathPCI
version 4 dataset. Logistic generalized estimating equation modeling was used to
compare in-hospital mortality adjusting for baseline patient characteristics.
Results: There were 64,613 patients who underwent PCI for intermediate coronary
stenoses. Of these patients, 4,472 (6.9%) underwent FFR, 13,233 (20.5%) underwent
IVUS, 832 (1.3%) had both, and 46,076 (71.3%) had neither. Patients were less likely
to undergo FFR in the setting of an acute coronary syndrome (ACS) (p<0.001), and
more likely to undergo FFR or IVUS if undergoing elective PCI (p<0.001 for both
comparisons)(Table). Prior stress testing was associated with higher rates of both IVUS
and FFR usage (p<0.001 for both). FFR was more likely if the PCI was performed in
a University setting as compared to a private or government hospital system(p<0.001).
There was no significant association between IVUS usage and either presence of an
ACS or the hospital type. After adjusting for comorbid conditions, neither FFR (OR
0.86 [0.42-1.74]; p=0.68) nor IVUS (OR 0.74 [0.50-1.08]; p=0.12) was significantly
associated with in-hospital mortality.
Conclusion: Despite the demonstration of the utility and benefit of both IVUS and
FFR technologies in the treatment of intermediate coronary stenoses, they currently
appear to be used in a minority of cases in which PCI is performed.
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Background: Recent data suggest that fractional flow reserve (FFR) is useful in
guiding coronary revascularization. There is however currently no large report of its
impact on the decision of coronary revascularization on an individual patient basis.
Methods: The R3F registry investigated the use of FFR in 20 French centers from
October 2008 to June 2010. To investigate this issue the investigators were asked to
define prospectively their revascularization strategy “a priori” before performing the
FFR. This was compared to the final strategy applied to the patient after performing
the FFR. The results of the first 945 consecutive patients are presented.
Results: 75% of patients were males with a mean age of 65±10 years, 37% were
diabetics and 19% had a recent ACS. Patients had nonsignificant (< 50% stenosis)
angiographic coronary artery disease (14%), significant (>50%) angiographic 1-vessel
(37%), 2-vessel (30%) or 3-vessel disease (19%). The strategy defined “apriori” by
the investigators was medical therapy in 52% and coronary revascularization in 48%
(PCI in 37% and CABG in 11%). After the results of FFR the final strategy applied to
the patient was medical therapy in 58% and coronary revascularization in 42% (PCI
in 31% and CABG in 11%). In individual patients the strategy defined “a priori” was
modified by the results of the FFR in 47% of the cases: 1) In 36% of the patients in
which medical therapy was the strategy “a priori”, it was modified for PCI (26%) or
CABG (10%). 2) In 58% of the patients in which a PCI was the strategy “a priori”, it
was modified for medical therapy (50%) or CABG (8%). 3) In 68% of the patients in
which a CABG was the strategy “a priori”, it was modified for medical therapy (64%)
or PCI (4%.
Conclusion: The present report, based on a large multicenter registry, demonstrated
that although FFR had little impact on the overall rate of revascularization, it modified
the individual decision in about 1 out of 2 patients. This data provides support to the
concept of “FFR guided revascularization” to tailor the revascularization strategy in
patients with CAD.
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